Wide Ranks

LFCR

Lifecore Biomedical, Inc.

7.50

Top Statistics
Market Cap 276 M Forward PE -10.48 Revenue Growth 0.70 %
Current Ratio 1.83 Trailing PE 57.65 Earnings Growth 0.00 %
Profit Margins 5.09 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -602.92 Enterprise / Revenue 3.16 Price To Sales Trailing12 Months 2.15
Profitability
Profit Margins 5.09 % Operating Margins -36.77 %
Balance Sheet
Total Cash 5 M Total Cash Per Share 0.1790 Total Debt 136 M
Total Debt To Equity 346.46 Current Ratio 1.83 Book Value Per Share -0.1270
All Measures
Short Ratio 1438.00 % Message Board Id finmb_30668 Shares Short Prior Month 2 M
Return On Equity 0.1729 City Chaska Uuid 82e9fd16-3df3-38a9-9aef-ea59ea68d834
Previous Close 7.44 First Trade Date Epoch Utc 824 M Book Value -0.1270
Beta 0.9390 Total Debt 136 M Volume 192047
Fifty Two Week Low 3.68 Total Cash Per Share 0.1790 Total Revenue 128 M
Shares Short Previous Month Date 1 B Target Median Price 8.00 Audit Risk 10
Max Age 86400 Recommendation Mean 2.33 Sand P52 Week Change 0.3133
Operating Margins -36.77 % Target Mean Price 8.00 Net Income To Common 5 M
Short Percent Of Float 0.1088 Implied Shares Outstanding 36 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 238710 Average Volume10days 238710
Total Cash 5 M Next Fiscal Year End 1 B Revenue Per Share 4.20
Held Percent Insiders 0.0532 Ebitda Margins -0.53 % Trailing PE 57.65
Date Short Interest 1 B Most Recent Quarter 1 B Share Holder Rights Risk 1
Regular Market Previous Close 7.44 Target Low Price 6.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 5.72 Open 7.50 Free Cashflow -10525250
State MN Dividend Yield 0.00 % Return On Assets -0.0225
Time Zone Short Name EST Board Risk 4 Trailing Eps 0.1300
Day Low 7.46 Address1 3515 Lyman Boulevard Shares Outstanding 36 M
Compensation Risk 6 Price Hint 2 Target High Price 10.00
Website https://www.lifecore.com 52 Week Change 0.0460 Average Volume 210298
Forward Eps -0.7100 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 75.70 % Is_sp_500 False Regular Market Day High 7.74
Profit Margins 5.09 % Debt To Equity 346.46 Fifty Two Week High 8.90
Day High 7.74 Shares Short 2 M Regular Market Open 7.50
Industry Key drug-manufacturers-specialty-generic Earnings Growth 0.00 % Enterprise To Revenue 3.16
Revenue Growth 0.70 % Shares Percent Shares Out 0.0670 Operating Cashflow 7 M
Currency USD Time Zone Full Name America/New_York Market Cap 276 M
Is_nasdaq_100 False Zip 55318 Quote Type EQUITY
Industry Drug Manufacturers - Specialty & Generic Long Name Lifecore Biomedical, Inc. Overall Risk 6
Regular Market Day Low 7.46 Held Percent Institutions 0.6957 Current Price 7.50
Enterprise To Ebitda -602.92 Financial Currency USD Current Ratio 1.83
Gross Margins 34.65 % Industry Disp Drug Manufacturers - Specialty & Generic Number Of Analyst Opinions 2
Country United States Float Shares 18 M Two Hundred Day Average 5.90
Governance Epoch Date 1 B Ir Website http://landec.com/investor/stock-information/ Price To Sales Trailing12 Months 2.15
Enterprise Value 406 M Forward PE -10.48 Regular Market Volume 192047
Ebitda -674000 Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States.

The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures.

It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products.

The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022.

Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.